ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
04 janv. 2024 08h00 HE
|
ProPhase Labs, Inc.
Company also plans to commercialize its BE-Smart Esophageal Cancer Test in 2024Company announces the hiring of long-time industry veteran Jed Latkin as COO to help build and manage this growth Garden...
Asia Pacific Multi-cancer Early Detection Market Report 2023: Market to Reach $404.75 Million by 2030 - Extensive R&D for the Development of MCED Fueling Growth
28 nov. 2023 08h13 HE
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Asia Pacific Multi-cancer Early Detection Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Gene Panel, LDT ), By End-use...
Asia Cervical Cancer Screening Markets, 2023-2028 with AstraZeneca, Hologic, Becton, Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health Dominating
06 nov. 2023 04h03 HE
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Blood Testing Market to hit USD 123 Billion by 2030, says Global Market Insights Inc.
26 sept. 2022 05h10 HE
|
Global Market Insights Inc.
Selbyville, Delaware , Sept. 26, 2022 (GLOBE NEWSWIRE) -- The blood testing market value is set to reach USD 123 billion by 2030, according to a new research report by Global Market Insights Inc....
Asia Cervical Cancer Test (Screening) Market Report 2022: Market will Reach $4.5 Billion by 2027 from $3.6 Billion in 2021
14 juin 2022 04h48 HE
|
Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19" report has been added to...
United States and Canada Cervical Cancer Screening Industry Forecast to Reach US$ 8.2 Billion by 2027
13 déc. 2021 04h18 HE
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "United States and Canada Cervical Cancer Screening Market, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Company Analysis" report has been...
Cervical Cancer Screening Market, 2026 - Patients, Mortality Forecast by Tests Type -Pap Smear, HPV DNA, VIA
08 févr. 2021 04h18 HE
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Cervical Cancer Screening Market, Patients, Mortality Global Forecast by Tests Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis" report has been...
Global Liver Cancer Diagnostic Tests Devices Pipeline Assessment 2020: Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials
22 déc. 2020 03h43 HE
|
Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "Liver Cancer...
LifeLabs partners with Bayer Inc. to offer clinicians a complimentary testing service to detect TRK fusion cancer
02 sept. 2020 12h30 HE
|
LifeLabs
Toronto, ON, Sept. 02, 2020 (GLOBE NEWSWIRE) -- LifeLabs is pleased announce it has partnered with Bayer Inc. to launch FastTRK, a complimentary clinical testing program for the diagnosis of...